MGO One Seven’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

MGO One Seven’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$0	Buy	+69	New	+$28	﹤0.01%	1977

Other funds holding GCVRZ

Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

New Generation Advisors Manchester, Massachusetts $45.6M AUM 15.43% 1-Year Est. Return

MGO One Seven's GCVRZ Position: Q1 2018 in Review

MGO One Seven opened a new position in Sanofi Contingent Value Rights (GCVRZ) in Q1 2018: 69 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #1977 among its holdings.

100 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2018.

MGO One Seven held 69 shares of Sanofi Contingent Value Rights worth $0 as of Q1 2018.
Sanofi Contingent Value Rights was a new MGO One Seven position in Q1 2018.
Sanofi Contingent Value Rights made up ﹤0.01% of MGO One Seven's portfolio in Q1 2018, its #1977 holding.
100 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2018.

Based on MGO One Seven's 13F filing for Q1 2018, filed 15 May 2018.